Publications

• Assessment of Glycemic Control Using Continuous Glucose Monitoring During Hospitalization and After Discharge for Older Adults.
  J Diabetes Sci Technol Page(s): 19322968251332656
  04/12/2025 Authors: Kantipudi S; Idrees T; Castro-Revoredo I; Vellanki P; Castejon-Rosales E; Petty K; Peng L; Umpierrez GE
• Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test.
  J Clin Endocrinol Metab Volume: 110 Page(s): e1108 - e1115
  03/17/2025 Authors: Stefanovski D; Smiley DD; Punjabi NM; Umpierrez GE; Vellanki P
• Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge.
  Endocr Pract Volume: 31 Page(s): 286 - 291
  03/01/2025 Authors: Umpierrez GE; Castro-Revoredo I; Moazzami B; Nayberg I; Zabala Z; Galindo RJ; Vellanki P; Peng L; Klonoff DC
• Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.
  Diabetes Care Volume: 48 Page(s): 118 - 124
  01/01/2025 Authors: Hirsch IB; Draznin B; Buse JB; Raghinaru D; Spanbauer C; Umpierrez GE; Ullal J; Jones MS; Low Wang CC; Spanakis EK
• Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study.
  BMJ Open Volume: 14 Page(s): e092503
  12/26/2024 Authors: Zaveri S; Stecenko A; Hunt WR; Goss A; Sharma P; Hartman TJ; Easley K; Chandler JD; Burley TM; Driggers C
• Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.
  Diabetes Care Volume: 47 Page(s): e63 - e64
  08/01/2024 Authors: Vellanki P; Umpierrez GE
• A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic -cell inactivation mechanisms.
  bioRxiv
  06/06/2024 Authors: Ridout SA; Vellanki P; Nemenman I
• Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
  J Am Med Dir Assoc Volume: 25 Page(s): 884 - 888
  05/01/2024 Authors: Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E
• Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
  Diabetes Care Volume: 47 Page(s): 267 - 271
  02/01/2024 Authors: Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T
• Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
  Endocr Pract Volume: 29 Page(s): 754 - 761
  10/01/2023 Authors: Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
• A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 9-15%: DUAL HIGH Trial.
  Diabetes Care Volume: 46 Page(s): 1640 - 1645
  09/01/2023 Authors: Galindo RJ; Moazzami B; Scioscia MF; Zambrano C; Albury BS; Saling J; Vellanki P; Pasquel FJ; Davis GM; Fayfman M
• Long-term insulin requirement after SARS-CoV-2 infection in youth with type 2 diabetes presenting with diabetic ketoacidosis
  Volume: 96 Page(s): 94 - 95
  07/26/2023 Authors: Hao S; Cossen K; Westbrook A; Umpierrez G; Vellanki P
• Diabetic retinopathy in African-Americans with end-stage kidney disease: a cross-sectional study on prevalence and impact on quality of life.
  BMJ Open Diabetes Res Care Volume: 11
  07/01/2023 Authors: Egeolu M; Caleon RL; Manishimwe E; Zabala ZE; Moazzami B; Gerges A; O'Keefe GD; Navarrete J; Galindo RJ; McCoy RG
• American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
  Endocr Pract Volume: 29 Page(s): 305 - 340
  05/01/2023 Authors: Samson SL; Vellanki P; Blonde L; Christofides EA; Galindo RJ; Hirsch IB; Isaacs SD; Izuora KE; Low Wang CC; Twining CL
• The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
  Diabetes Res Clin Pract Volume: 198 Page(s): 110603
  04/01/2023 Authors: Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L
• Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.
  Endocrinol Metab Clin North Am Volume: 52 Page(s): 27 - 38
  03/01/2023 Authors: Hao S; Umpierrez GE; Daley T; Vellanki P
• Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2.
  Endocrinol Metab Clin North Am Volume: 52 Page(s): 39 - 47
  03/01/2023 Authors: Hao S; Umpierrez GE; Vellanki P
• SARS-CoV-2 does not increase severity of diabetic ketoacidosis in children and adolescents with new onset ketosis prone diabetes
  Volume: 365 Page(s): S68 - S68
  02/01/2023 Authors: Hao S; Cossen K; Vellanki P
• Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial.
  J Diabetes Sci Technol Volume: 17 Page(s): 201 - 207
  01/01/2023 Authors: Galindo RJ; Ramos C; Cardona S; Vellanki P; Davis GM; Oladejo O; Albury B; Dhruv N; Peng L; Umpierrez GE
• Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.
  Front Nutr Volume: 10 Page(s): 1158452
  01/01/2023 Authors: Daley TC; Cousineau BA; Nesbeth P-DC; Ivie EA; Bellissimo MP; Easley KA; Vellanki P; Vos MB; Hunt WR; Stecenko AA
• Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
  Diabetes Care Volume: 45 Page(s): 2217 - 2223
  10/01/2022 Authors: Vellanki P; Cardona S; Galindo RJ; Urrutia MA; Pasquel FJ; Davis GM; Fayfman M; Migdal A; Peng L; Umpierrez GE
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
  Endocr Pract Volume: 28 Page(s): 923 - 1049
  10/01/2022 Authors: Blonde L; Umpierrez GE; Reddy SS; McGill JB; Berga SL; Bush M; Chandrasekaran S; DeFronzo RA; Einhorn D; Galindo RJ
• Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
  Diabetes Care Volume: 45 Page(s): 2369 - 2375
  10/01/2022 Authors: Spanakis EK; Urrutia A; Galindo RJ; Vellanki P; Migdal AL; Davis G; Fayfman M; Idrees T; Pasquel FJ; Coronado WZ
• Efficacy and safety of real-time continuous glucose monitoring guiding insulin administration in the hospital: a randomised clinical trial
  Volume: 65 Page(s): S53 - S53
  09/01/2022 Authors: Umpierrez GE; Galindo RJ; Urrutia MA; Vellanki P; Migdal AL; Davis GM; Pasquel FJ; Fayfman M; Idrees T; Peng L
• Kynurenine Metabolism as a Mechanism to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors Following Resistance Training.
  J Funct Morphol Kinesiol Volume: 7
  06/01/2022 Authors: Robbins RN; Kelleher JL; Vellanki P; O'Connor JC; Mascaro JS; Nocera JR; Serra MC
• Inpatient Glycemic Control and Glucose Variability by Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes
  Volume: 71
  06/01/2022 Authors: Idrees T; Galindo RJ; Urrutia MA; Castro-Revoredo IA; Moreno EM; Migdal AL; Davis GM; Vellanki P; Fayfman M; Pasquel FJ
• Management of Inpatient Hyperglycemia Guided by Continuous Glucose Monitoring (CGM) in Insulin-Treated Patients with Diabetes-A Randomized Clinical Trial
  Volume: 71
  06/01/2022 Authors: Spanakis IE; Urrutia MA; Scioscia MF; Galindo RJ; Vellanki P; Migdal AL; Davis GM; Idrees T; Pasquel FJ; Singh LG
• Insulin Secretion at Diabetes Remission in Obese Blacks Presenting with Diabetic Ketoacidosis
  Volume: 71
  06/01/2022 Authors: Stefanovski D; Oladejo O; Umpierrez GE; Vellanki P
• Cell-Free DNA Methylation as a Biomarker of Islet-Cell Death in Youth with Type 2 Diabetes
  Volume: 71
  06/01/2022 Authors: Staimez LR; Ham JN; Daley T; Vellanki P; Smith AK; Narayan KMV; Baccarelli A; Conneely K
• Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.
  Diabetes Obes Metab Volume: 24 Page(s): 42 - 49
  01/01/2022 Authors: Galindo RJ; Pasquel FJ; Vellanki P; Alicic R; Lam DW; Fayfman M; Migdal AL; Davis GM; Cardona S; Urrutia MA
• 1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Survival in Obese Black Patients With Hyperglycemic Crises.
  Front Endocrinol (Lausanne) Volume: 13 Page(s): 871965
  01/01/2022 Authors: Jagannathan R; Stefanovski D; Smiley DD; Oladejo O; Cotten LF; Umpierrez G; Vellanki P
• Diabetic ketoacidosis risk during the COVID-19 pandemic.
  Lancet Diabetes Endocrinol Volume: 9 Page(s): 643 - 644
  10/01/2021 Authors: Vellanki P; Umpierrez GE
• Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes.
  Diabetes Care Volume: 44 Page(s): 1641 - 1646
  07/01/2021 Authors: Davis GM; Spanakis EK; Migdal AL; Singh LG; Albury B; Urrutia MA; Zamudio-Coronado KW; Scott WH; Doerfler R; Lizama S
• Biochemical Parameters of Diabetes Ketoacidosis in Patients with End-stage Kidney Disease and Preserved Renal Function.
  J Clin Endocrinol Metab Volume: 106 Page(s): e2673 - e2679
  06/16/2021 Authors: Galindo RJ; Pasquel FJ; Vellanki P; Zambrano C; Albury B; Perez-Guzman C; Ziduo Z; Umpierrez GE
• Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
  Diabetes Obes Metab Volume: 23 Page(s): 1351 - 1360
  06/01/2021 Authors: Pasquel FJ; Urrutia MA; Cardona S; Coronado KWZ; Albury B; Perez-Guzman MC; Galindo RJ; Chaudhuri A; Iacobellis G; Palacios J
• One-Hour Glucose during Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse in Black Obese Patients with Hyperglycemic Crises
  Volume: 70
  06/01/2021 Authors: Jagannathan R; Smiley-Byrd D; Stefanovski D; Umpierrez GE; Vellanki P
• Comparison of Dexcom G6 Continuous Glucose Monitoring Performance between Abdomen and Upper Arm Placement in Hospitalized Patients with Diabetes
  Volume: 70
  06/01/2021 Authors: Migdal A; Zamudio KW; Perez-Guzman MC; Idrees T; Albury BS; Davis G; Urrutia MA; Galindo RJ; Vellanki P; Fayfman M
• Performance Evaluation of Dexcom G6 Continuous Glucose Monitoring and Capillary Blood Glucose after Hospital Discharge in Patients with Diabetes
  Volume: 70
  06/01/2021 Authors: Galindo RJ; Davis G; Idrees T; Urrutia MA; Zamudio KW; Albury BS; Migdal A; Vellanki P; Fayfman M; Perez-Guzman MC
• Comparison of Dexcom G6 Continuous Glucose Monitoring and Point -of-Care Blood Glucose Testing in Hospitalized Patients with Diabetes
  Volume: 70
  06/01/2021 Authors: Davis GM; Migdal A; Urrutia MA; Zamudio-Coronado KW; Perez-Guzman MC; Albury BS; Cardona S; Galindo RJ; Idrees T; Vellanki P
• A Comparison of Cognitive Outcomes associated with Hypoglycemia among Younger and Older Adults
  Volume: 69 Page(s): S58 - S58
  04/01/2021 Authors: Garay PAS; Vellanki P; Cardona S; Umpierrez G; Ohuabunwa U
• Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.
  Diabetes Obes Metab Volume: 23 Page(s): 480 - 488
  02/01/2021 Authors: Cardona S; Tsegka K; Pasquel FJ; Jacobs S; Halkos M; Keeling WB; Davis GM; Fayfman M; Albury B; Urrutia MA
• Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
  AACE Clin Case Rep Volume: 7 Page(s): 36 - 39
  01/01/2021 Authors: Patel AM; Stanback C; Vellanki P
• A Case of Severe Hypocalcemia Caused by Malabsorption Due to Partial Gastrectomy and Small Bowel Resection.
  AACE Clin Case Rep Volume: 7 Page(s): 323 - 326
  01/01/2021 Authors: Knight JO; Cotten LF; Ziegler TR; Vellanki P
• Differences in Oral Glucose Response Curve Shapes in African American Men and Women Presenting with Ketosis-Prone Diabetes
  Volume: 29 Page(s): A5 - A6
  12/01/2020 Authors: Vellanki P; Cotton L; Stefanovski D; Oladejo O; Umpierrez G
• Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.
  Diabetes Care Volume: 43 Page(s): 2730 - 2735
  11/01/2020 Authors: Galindo RJ; Migdal AL; Davis GM; Urrutia MA; Albury B; Zambrano C; Vellanki P; Pasquel FJ; Fayfman M; Peng L
• QUALITY OF DIETARY FATS AND OTHER MACRONUTRIENTS ARE ASSOCIATED WITH GLYCEMIC OUTCOMES IN ADULTS WITH CF
  Volume: 55 Page(s): S81 - S81
  10/01/2020 Authors: Daley T; Alvarez JA; Nesbeth P; Cousineau B; Bellissimo MP; Vellanki P; Vos M; Stecenko A; Ziegler TR; Ivie EA
• Population insulin sensitivity from sparsely sampled oral glucose tolerance tests.
  Metabolism Volume: 110 Page(s): 154298
  09/01/2020 Authors: Stefanovski D; Vellanki P; Smiley-Byrd DD; Umpierrez GE; Boston RC
• Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic.
  J Diabetes Sci Technol Volume: 14 Page(s): 822 - 832
  07/01/2020 Authors: Galindo RJ; Aleppo G; Klonoff DC; Spanakis EK; Agarwal S; Vellanki P; Olson DE; Umpierrez GE; Davis GM; Pasquel FJ
• Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks.
  BMJ Open Diabetes Res Care Volume: 8
  07/01/2020 Authors: Gujral UP; Johnson L; Nielsen J; Vellanki P; Haw JS; Davis GM; Weber MB; Pasquel FJ
• Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes.
  Endocr Pract Volume: 26 Page(s): 722 - 728
  07/01/2020 Authors: Lorenzo-Gonzlez C; Atienza-Snchez E; Reyes-Umpierrez D; Vellanki P; Davis GM; Pasquel FJ; Cardona S; Fayfman M; Peng L; Umpierrez GE
• A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
  Diabetes Care Volume: 43 Page(s): 1242 - 1248
  06/01/2020 Authors: Pasquel FJ; Lansang MC; Khowaja A; Urrutia MA; Cardona S; Albury B; Galindo RJ; Fayfman M; Davis G; Migdal A
• The Shape of Glucose Response Curve during Oral Glucose Tolerance Tests (OGTT) and Long-Term Near-Normoglycemia Remission in African Americans Presenting with Hyperglycemic Crises
  Volume: 69
  06/01/2020 Authors: Cotten L; Stefanovski D; Oladejo O; Umpierrez GE; Vellanki P
• Randomized Controlled Trial on the Efficacy of Supplemental Rapid-Acting Insulin during Basal-Bolus Regimen in Non-ICU Patients with Type 2 Diabetes
  Volume: 69
  06/01/2020 Authors: Vellanki P; Cardona S; Urrutia MA; Galindo RJ; Davis G; Haw JS; Fayfman M; Migdal A; Guo Y; Pasquel FJ
• Immune Checkpoint Inhibitor Induced Diabetes and Diabetic Ketoacidosis
  Volume: 69
  06/01/2020 Authors: Hafeez S; Vellanki P; Xing M; Umpierrez GE
• Home Diabetes Regimen and Admission HbA1c as Predictors of Hospital Glycemic Control: A Pooled Analysis of Inpatient Clinical Trials
  Volume: 69
  06/01/2020 Authors: Urrutia MA; Guo Y; Fayfman M; Vellanki P; Galindo RJ; Migdal A; Davis G; Anzola I; Albury BS; Scioscia MF
• Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises.
  BMJ Open Diabetes Res Care Volume: 8
  05/01/2020 Authors: Vellanki P; Stefanovski D; Anzola II; Smiley DD; Peng L; Umpierrez GE
• SAFETY AND EFFICACY OF DDP4-INHIBITORS FOR MANAGEMENT OF HOSPITALIZED GENERAL MEDICINE AND SURGERY PATIENTS WITH TYPE 2 DIABETES.
  Endocr Pract
  04/27/2020 Authors: Lorenzo-Gonzlez C; Atienza-Snchez E; Reyes-Umpierrez D; Vellanki P; Davis GM; Pasquel FJ; Cardona S; Fayfman M; Peng L; Umpierrez GE
• Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.
  Diabetes Care Volume: 43 Page(s): 349 - 357
  02/01/2020 Authors: Pasquel FJ; Tsegka K; Wang H; Cardona S; Galindo RJ; Fayfman M; Davis G; Vellanki P; Migdal A; Gujral U
• Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis.
  BMJ Open Diabetes Res Care Volume: 8
  02/01/2020 Authors: Galindo RJ; Pasquel FJ; Fayfman M; Tsegka K; Dhruv N; Cardona S; Wang H; Vellanki P; Umpierrez GE
• Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
  Circulation Volume: 140 Page(s): 1463 - 1476
  10/29/2019 Authors: Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B
• Glycemic Control During Gender-Affirming Therapy in a Patient With Type 1 Diabetes.
  Clin Diabetes Volume: 37 Page(s): 398 - 400
  10/01/2019 Authors: Campbell SH; Flint KL; Haw JS; Davis GM; Vellanki P
• Normal Glucose Tolerance (NGT) in Obese African-Americans (AA) with Ketosis-Prone Diabetes (KPDM)
  Volume: 68
  06/01/2019 Authors: Vellanki P; Stefanovski D; Narwani V; Anzola I; Peng L; Smiley-Byrd D; Umpierrez GE
• A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
  Volume: 68
  06/01/2019 Authors: Pasquel FJ; Lansang MC; Khowaja A; Galindo RJ; Urrutia MA; Cardona S; Shakally A; Lyerla RC; Anzola I; Albury BS
• Differences in Glucose Absorption in African American (AA) Patients Presenting with DKA and Severe Hyperglycemia (SH)
  Volume: 68
  06/01/2019 Authors: Stefanovski D; Umpierrez GE; Boston RC; Vellanki P
• Accuracy Comparison of the Freestyle Libre Pro Continuous Glucose Monitoring (CGM) and Point-of-Care (POC) Testing in Noncritically Ill Hospitalized Patients with Type 2 Diabetes Treated with Basal-Bolus Insulin Regimen
  Volume: 68
  06/01/2019 Authors: Galindo RJ; Urrutia MA; Davis G; Khowaja A; Albury BS; Anzola I; Johnson AA; Vellanki P; Cardona S; Fayfman M
• Sitagliptin for the Prevention and Treatment of Perioperative Hyperglycemia in Diabetic Patients Undergoing Cardiac Surgery
  Volume: 68
  06/01/2019 Authors: Cardona S; Tsegka KG; Jacobs S; Albury BS; Galindo RJ; Migdal A; Halkos ME; Keeling WB; Miller JS; Macheers SK
• Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
  Diabetes Obes Metab Volume: 21 Page(s): 837 - 843
  04/01/2019 Authors: Vellanki P; Rasouli N; Baldwin D; Alexanian S; Anzola I; Urrutia M; Cardona S; Peng L; Pasquel FJ; Umpierrez GE
• A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
  Diabetes Care Volume: 42 Page(s): 450 - 456
  03/01/2019 Authors: Fayfman M; Galindo RJ; Rubin DJ; Mize DL; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P
• Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631-1638.
  Diabetes Care Volume: 42 Page(s): e24
  02/01/2019 Authors: Galindo RJ; Zambrano C; Vellanki P
• Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.
  BMJ Open Diabetes Res Care Volume: 7 Page(s): e000703
  01/01/2019 Authors: Cardona S; Tsegka K; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Halkos M; Guyton RA; Thourani VH
• Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.
  J Diabetes Complications Volume: 32 Page(s): 1091 - 1096
  12/01/2018 Authors: Fayfman M; Davis G; Duggan EW; Urrutia M; Chachkhiani D; Schindler J; Pasquel FJ; Galindo RJ; Vellanki P; Reyes-Umpierrez D
• Sex- and Non Sex-Specific Differences in Carbohydrate Tolerance During Remission in Patients with Ketosis-Prone Diabetes
  Volume: 27 Page(s): 1432 - 1432
  11/01/2018 Authors: Vellanki P; Stefanovski D; Anzola I; Smiley DD; Peng L; Umpierrez GE
• Carbohydrate tolerance at near-normoglycaemia remission in obese African American patients with hyperglycaemic crises
  Volume: 61 Page(s): S340 - S340
  10/01/2018 Authors: Vellanki P; Stefanovski D; Narwani V; Anzola I; Smiley DD; Peng L; Umpierrez GE
• Glycaemic efficacy and safety of linagliptin compared to basal bolus insulin regimen in non-cardiac surgical patients with type 2 diabetes: Linagliptin-Surgery trial
  Volume: 61 Page(s): S377 - S378
  10/01/2018 Authors: Umpierrez G; Vellanki P; Rasouli N; Baldwin D; Alexanian S; Anzola I; Urrutia M; Gomez P; Cardona S; Wang H
• Increasing Hospitalizations for DKA: A Need for Prevention Programs.
  Diabetes Care Volume: 41 Page(s): 1839 - 1841
  09/01/2018 Authors: Vellanki P; Umpierrez GE
• Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
  Fertil Steril Volume: 110 Page(s): 523 - 533.e14
  08/01/2018 Authors: Yilmaz B; Vellanki P; Ata B; Yildiz BO
• Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed.
  J Diabetes Complications Volume: 32 Page(s): 650 - 654
  07/01/2018 Authors: VanderWeele J; Pollack T; Oakes DJ; Smyrniotis C; Illuri V; Vellanki P; O'Leary K; Holl J; Aleppo G; Molitch ME
• Racial and Socioeconomic Disparities in Meeting Goals of Care in Adults with Type 1 Diabetes
  Volume: 67
  07/01/2018 Authors: Haw JS; Peng L; Pasquel FJ; Vellanki P; Fayfman M; Davis G; Umpierrez GE
• Characteristics and Mortality of Recurrent Diabetic Ketoacidosis (DKA) in Adults and Children with Type 1 Diabetes (T1D)
  Volume: 67
  07/01/2018 Authors: Vellanki P; Peng L; Dhruv N; Ramos C; Haw JS; Galindo RJ; Davis G; Fayfman M; Pasquel FJ; Umpierrez GE
• Simplified Transition Algorithm from Intravenous to Subcutaneous Insulin in Nondiabetic Cardiac Surgery Patients with Stress Hyperglycemia
  Volume: 67
  07/01/2018 Authors: Cardona S; Galindo RJ; Tsegka KG; Urrutia MA; Vellanki P; Fayfman M; Haw JS; Pasquel FJ; Peng L; Umpierrez GE
• Safety and Efficacy of Exenatide Therapy for the Management of Hospitalized Patients with Type 2 Diabetes-Exenatide Hospital Trial
  Volume: 67
  07/01/2018 Authors: Fayfman M; Mize DL; Rubin DJ; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P; Wang H
• Clinical Characteristics and Outcomes in Patients Admitted with Diabetic Ketoacidosis (DKA) and End-Stage Renal Disease (ESRD)
  Volume: 67
  07/01/2018 Authors: Galindo RJ; Pasquel FJ; Tsegka KG; Cardona S; Dhruv N; Vellanki P; Fayfman M; Haw JS; Migdal A; Nair S
• Clinical Outcomes and Mortality among Patients Hospitalized with Hypoglycemia and End-Stage Renal Disease in the US
  Volume: 67
  07/01/2018 Authors: Galindo RJ; Hurtado CR; Pasquel FJ; Vellanki P; Umpierrez GE
• THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.
  Endocr Pract Volume: 24 Page(s): 556 - 564
  06/01/2018 Authors: Gianchandani RY; Pasquel FJ; Rubin DJ; Dungan KM; Vellanki P; Wang H; Anzola I; Gomez P; Hodish I; Lathkar-Pradhan S
• A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
  J Am Med Dir Assoc Volume: 19 Page(s): 399 - 404.e3
  05/01/2018 Authors: Umpierrez GE; Cardona S; Chachkhiani D; Fayfman M; Saiyed S; Wang H; Vellanki P; Haw JS; Olson DE; Pasquel FJ
• Stress hyperglycemia in general surgery: Why should we care?
  J Diabetes Complications Volume: 32 Page(s): 305 - 309
  03/01/2018 Authors: Davis G; Fayfman M; Reyes-Umpierrez D; Hafeez S; Pasquel FJ; Vellanki P; Haw JS; Peng L; Jacobs S; Umpierrez GE
• Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
  Fertil Steril Volume: 109 Page(s): 356 - 364.e32
  02/01/2018 Authors: Yilmaz B; Vellanki P; Ata B; Yildiz BO
• Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes.
  BMJ Open Diabetes Res Care Volume: 6 Page(s): e000607
  01/01/2018 Authors: Cardona S; Gomez PC; Vellanki P; Anzola I; Ramos C; Urrutia MA; Haw JS; Fayfman M; Wang H; Galindo RJ
• DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
  Endocr Pract Volume: 23 Page(s): 971 - 978
  08/01/2017 Authors: Vellanki P; Umpierrez GE
• Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
  Metabolism Volume: 71 Page(s): 125 - 131
  06/01/2017 Authors: Sam S; Vellanki P; Yalamanchi SK; Bergman RN; Dunaif A
• Sitagliptin for the Prevention of Stress Hyperglycemia in Nondiabetic Patients Undergoing Cardiac Surgery
  Volume: 66 Page(s): A341 - A341
  06/01/2017 Authors: Cardona S; Tsegka K; Thourani VH; Halkos M; Guyton RA; Pasquel FJ; Vellanki P; Fayfman M; Haw JS; Peng L
• DPP-4 Inhibitors for the Inpatient Management of General Medicine and Surgery Patients with Type 2 Diabetes
  Volume: 66 Page(s): A342 - A343
  06/01/2017 Authors: Reyes-Umpierrez D; Davis G; Peng L; Pasquel F; Vellanki P; Jacobs S; Fayfman M; Haw S; Umpierrez GE
• Asymptomatic Hypoglycemia in Non-ICU Patients with Diabetes
  Volume: 66 Page(s): A109 - A109
  06/01/2017 Authors: Haw JS; Gomez P; Anzola I; Ramos C; Urrutia M; Cardona S; Vellanki P; Pasquel F; Fayfman M; Wang H
• A Randomized Controlled Study Comparing Linagliptin and Glargine Insulin in Long-Term Care Residents with Type 2 Diabetes
  Volume: 66 Page(s): A341 - A341
  06/01/2017 Authors: Umpierrez GE; Chachkhiani D; Cardona S; Saiyed S; Wang H; Johnson T; Doan J; Vellanki P; Fayfman M; Haw S
• Efficacy and Safety of Linagliptin in General Surgical Patients with Type 2 Diabetes: Linagliptin Surgery Trial
  Volume: 66 Page(s): A336 - A336
  06/01/2017 Authors: Vellanki P; Alexanian S; Baldwin D; Rasouli N; Anzola IA; Ramos C; Urrutia MA; Jones J; Modzelewski K; Ensminger E
• Transition of Diabetes Care in Surgery Patients with Type 2 Diabetes (T2D) Using an HbA1c-Based Algorithm
  Volume: 66 Page(s): LB44 - LB44
  06/01/2017 Authors: Rasouli N; Vellanki P; Alexanian S; Baldwin D; Anzola I; Ramos C; Urrutia MA; Modzelewski K; Pasquel FJ; Fayfman M
• Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).
  Curr Diab Rep Volume: 17 Page(s): 33
  05/01/2017 Authors: Dhatariya KK; Vellanki P
• Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy.
  J Diabetes Complications Volume: 31 Page(s): 742 - 747
  04/01/2017 Authors: Cardona S; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Weaver J; Halkos M; Guyton RA; Thourani VH
• PERIOPERATIVE STRESS HYPERGLYCEMIA AND RISK OF COMPLICATIONS AND MORTALITY IN NON-DIABETIC PATIENTS UNDERGOING GENERAL SURGERY
  Volume: 65 Page(s): 635 - 635
  02/01/2017 Authors: Davis G; Fayfman M; Reyes D; Pasquel F; Vellanki P; Haw J; Peng L; Umpierrez GE
• USE OF ORAL AGENTS (DIPEPTIDYL PEPTIDASE 4 INHIBITORS) FOR THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES: SITA-HOSPITAL TRIAL
  Volume: 65 Page(s): 632 - 632
  02/01/2017 Authors: Anzola I; Pasquel F; Gomez P; Peng L; Haw J; Fayfman M; Vellanki P; Umpierrez GE
• CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH COMBINED DIABETIC KETOACIDOSIS AND HYPEROSMOLAR HYPERGLYCEMIC CRISES
  Volume: 65 Page(s): 634 - 634
  02/01/2017 Authors: Tsegka K; Cardona SD; Nair S; Vellanki P; Narayan K; Umpierrez GE; Pasquel F
• HOSPITAL DISCHARGE ALGORITHM BASED ON ADMISSION HBA1C FOR THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES; SITAGLIPTIN SITAGLIPTIN DISCHARGE TRIAL
  Volume: 65 Page(s): 632 - 633
  02/01/2017 Authors: Cardona SD; Vellanki P; Anzola I; Gomez P; Pasquel F; Umpierrez GE
• Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets.
  J Clin Endocrinol Metab Volume: 102 Page(s): 309 - 315
  01/01/2017 Authors: Reyes-Umpierrez D; Davis G; Cardona S; Pasquel FJ; Peng L; Jacobs S; Vellanki P; Fayfman M; Haw S; Halkos M
• Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises.
  Diabetes Care Volume: 39 Page(s): 1948 - 1955
  11/01/2016 Authors: Vellanki P; Smiley DD; Stefanovski D; Anzola I; Duan W; Hudson M; Peng L; Pasquel FJ; Umpierrez GE
• Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus.
  Evid Based Med Volume: 21 Page(s): 104 - 105
  06/01/2016 Authors: Vellanki P; Umpierrez G
• Metabolic Pathways Associated with Diabetic Ketoacidosis (DKA) Severity and DKA Resolution (DKA)
  Volume: 65 Page(s): A413 - A413
  06/01/2016 Authors: Pasquel FJ; Chong EY; Vellanki P; Jones DP; Ziegler TR; Umpierrez GE
• Perioperative Stress Hyperglycemia and Risk of Complications and Mortality in Nondiabetic Patients Undergoing General Surgery
  Volume: 65 Page(s): A384 - A385
  06/01/2016 Authors: Davis G; Fayfman M; Reyes D; Pasquel F; Vellanki P; Haw S; Peng L; Umpierrez GE
• Gene Expression Changes and Insulin Remission in Patients with Ketosis-Prone Diabetes
  Volume: 65 Page(s): A428 - A428
  06/01/2016 Authors: Vellanki P; Parets SE; Smiley DD; Pasquel FJ; Anzola I; Smith AK; Umpierrez GE
• Acute and Long-Term Neuroanatomical and Cognitive Changes in Adult Patients with First and Recurrent Episodes of Diabetic Ketoacidosis (DKA)
  Volume: 65 Page(s): A203 - A203
  06/01/2016 Authors: Ennis GE; Allen JW; Doan J; Behbahani K; Chachkhiani D; Powell W; Haw JS; Pasquel F; Vellanki P; Fayfman M
• Validation of Electronic Medical Record Data in Diabetic Ketoacidosis
  Volume: 65 Page(s): A384 - A384
  06/01/2016 Authors: Vanderweele J; Derby T; Oakes DJ; Smyrniotis C; Illuri VD; Vellanki P; O'Leary K; Holl J; Aleppo G; Molitch ME
• Asymptomatic Hypoglycemia in Hospitalized Patients with Diabetes: Prevalence, Risk Factors, and Outcomes
  Volume: 65 Page(s): A543 - A543
  06/01/2016 Authors: Gomez PC; Anzola I; Urrutia MA; Fayfman M; Vellanki P; Pasquel F; Haw S; Peng L; Umpierrez GE
• Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome: Clinical Characteristics and Outcome
  Volume: 65 Page(s): A387 - A387
  06/01/2016 Authors: Pasquel FJ; Vellanki P; Fayfman M; Oyedokun F; Haw S; Narayan KMV; Umpierrez GE
• Report on Racial Disparities in Hospitalized Patients with Hyperglycemia and Diabetes.
  J Clin Endocrinol Metab Volume: 101 Page(s): 1144 - 1150
  03/01/2016 Authors: Fayfman M; Vellanki P; Alexopoulos A-S; Buehler L; Zhao L; Smiley D; Haw S; Weaver J; Pasquel FJ; Umpierrez GE
• Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes.
  BMJ Open Diabetes Res Care Volume: 4 Page(s): e000200
  01/01/2016 Authors: Alexopoulos A-S; Fayfman M; Zhao L; Weaver J; Buehler L; Smiley D; Pasquel FJ; Vellanki P; Haw JS; Umpierrez GE
• COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
  Endocr Pract Volume: 21 Page(s): 1333 - 1343
  12/01/2015 Authors: Haw JS; Farrokhi F; Smiley D; Peng L; Reyes D; Newton C; Pasquel FJ; Vellanki P; Umpierrez GE
• Predictive Value of Admission Hemoglobin A1c on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes.
  Diabetes Care Volume: 38 Page(s): e202 - e203
  12/01/2015 Authors: Pasquel FJ; Gomez-Huelgas R; Anzola I; Oyedokun F; Haw JS; Vellanki P; Peng L; Umpierrez GE
• Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.
  Diabetes Care Volume: 38 Page(s): 1665 - 1672
  09/01/2015 Authors: Umpierrez G; Cardona S; Pasquel F; Jacobs S; Peng L; Unigwe M; Newton CA; Smiley-Byrd D; Vellanki P; Halkos M
• National Strategies to Decrease the Burden of Diabetes and Its Complications.
  Curr Diab Rep Volume: 15 Page(s): 65
  09/01/2015 Authors: Haw JS; Tantry S; Vellanki P; Pasquel FJ
• Body Mass Index, Diabetes Type, and Mortality after Cardiac Transplantation
  Volume: 64 Page(s): A477 - A477
  06/01/2015 Authors: Galindo RJ; Harris YT; Wallia A; Stein J; Vellanki P; Umpierrez GE
• Hypoglycemia between Treatment with Oral Agents and Basal Insulin in Elderly Patients with Type 2 Diabetes in Long-Term Care Facilities
  Volume: 64 Page(s): A106 - A106
  06/01/2015 Authors: Pasquel FJ; Powell W; Smiley DD; Peng L; Vellanki P; Haw S; Umpierrez GE; Doan J
• Efficacy and Safety of Oral Antidiabetic Drug Therapy in General Hospitalized Population with Type 2 Diabetes
  Volume: 64 Page(s): A329 - A329
  06/01/2015 Authors: Pasquel F; Fayfman M; Vellanki P; Haw S; Smiley DD; Zhao L; Nair S; Weaver J; Umpierrez GE
• Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
  Diabetes Care Volume: 38 Page(s): 568 - 574
  04/01/2015 Authors: Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
• Iatrogenic hypoglycemia and quality of life in patients with type 2 diabetes mellitus.
  Rev Clin Esp (Barc) Volume: 215 Page(s): 104 - 106
  03/01/2015 Authors: Vellanki P; Umpierrez GE
• The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients.
  J Diabetes Complications Volume: 29 Page(s): 1177 - 1182
  01/01/2015 Authors: Buehler L; Fayfman M; Alexopoulos A-S; Zhao L; Farrokhi F; Weaver J; Smiley-Byrd D; Pasquel FJ; Vellanki P; Umpierrez GE
• Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.
  J Clin Endocrinol Metab Volume: 99 Page(s): 2961 - 2966
  08/01/2014 Authors: Kobaly K; Vellanki P; Sisk RK; Armstrong L; Lee JY; Lee J; Hayes MG; Urbanek M; Legro RS; Dunaif A
• Assessing Current Management of Inpatient Diabetic Ketoacidosis Using Quality Improvement Methodology
  DIABETES Volume: 63 Page(s): A622 - A622
  06/01/2014 Authors: Therasse A; Vellanki P; Springer EJ; Oakes DJ; O'Leary K; Molitch ME; Holl J; Aleppo G; Wallia A
• Association of Glycemic Control, Inflammatory Markers and Peri-Operative Complications in Patients Undergoing CABG
  ENDOCRINE REVIEWS Volume: 35
  06/01/2014 Authors: Pasquel FJ; Vellanki P; Cardona S; Anzola I; Fayfman M; Peng L; Smiley D; Umpierrez GE
• Mapping Missing Heritability in PCOS: Developing Interpretive and Validation Methodology for Identifying the Contribution of Rare Variants to PCOS
  ENDOCRINE REVIEWS Volume: 35
  06/01/2014 Authors: Daviau E; Vellanki P; Torchen L; Sisk R; Werstein B; Legro RS; Urbanek M; Hayes MG; Dunaif A
• Obese Women with PCOS Have Reduced Liver Glucokinase Activity
  ENDOCRINE REVIEWS Volume: 35
  06/01/2014 Authors: Vellanki P; Stefanovski D; Bergman RN; Dunaif A
• Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
  J Clin Endocrinol Metab Volume: 99 Page(s): 387 - 390
  02/01/2014 Authors: Vellanki P; Lange K; Elaraj D; Kopp PA; El Muayed M
• FASTING GLUCOSE LEVELS DO NOT PREDICT IMPAIRED GLUCOSE TOLERANCE (IGT) IN POLYCYSTIC OVARY SYNROME (PCOS)
  Volume: 100 Page(s): S361 - S361
  09/01/2013 Authors: Kuang H; Vellanki P; Dodson WC; Kunselman AR; Dunaif A; Legro RS
• Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.
  Hum Reprod Volume: 28 Page(s): 770 - 776
  03/01/2013 Authors: Sasidevi A; Vellanki P; Kunselman AR; Raja-Khan N; Dunaif A; Legro RS